Education
About Us
Working with TipRanks
Follow Us
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
SXTP Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SXTP Stock 12 Month Forecast
Average Price Target
$4.40
▲(417.65% Upside)
| Highest Price Target$6.00 | Average Price Target$4.40 | Lowest Price Target$2.80 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ascendiant
$2.8
Buy
229.41%
Upside
Reiterated
11/27/25
We are lowering our FY25 EPS estimate to $(3.15) from $(2.72) on higher operating expenses, partially offset by higher revenues and higher share count, with FY25 revenue estimate raised to $1.5 million from $0.9 million. We are raising our FY26 EPS estimate to $(1.97) from $(2.00) on revenues of $1.7 million (up from $1.5 million previously). Subsequent financings extend runway: The company exited the September quarter with $4.1 million cash on hand. After the close of Q3, the company raised approximately $2.3 million in a registered direct offering. With a burn rate of roughly $1.5 million per quarter, we estimate the company has runway through 1H26.
H.C. Wainwright
$6
Buy
605.88%
Upside
Initiated
11/14/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Ascendiant
$2.8
Buy
229.41%
Upside
Reiterated
11/27/25
We are lowering our FY25 EPS estimate to $(3.15) from $(2.72) on higher operating expenses, partially offset by higher revenues and higher share count, with FY25 revenue estimate raised to $1.5 million from $0.9 million. We are raising our FY26 EPS estimate to $(1.97) from $(2.00) on revenues of $1.7 million (up from $1.5 million previously). Subsequent financings extend runway: The company exited the September quarter with $4.1 million cash on hand. After the close of Q3, the company raised approximately $2.3 million in a registered direct offering. With a burn rate of roughly $1.5 million per quarter, we estimate the company has runway through 1H26.
H.C. Wainwright
$6
Buy
605.88%
Upside
Initiated
11/14/25
Best Analysts Covering 60 Degrees Pharmaceuticals, Inc.
1 Month
xxx
Success Rate
2/7 ratings generated profit
Average Return
-4.01%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 28.57% of your transactions generating a profit, with an average return of -4.01% per trade.
3 Months
xxx
Success Rate
1/7 ratings generated profit
Average Return
-22.99%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -22.99% per trade.
1 Year
Success Rate
0/7 ratings generated profit
Average Return
-70.71%
reiterated a buy rating 18 days ago
Copying Lucas Ward's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.71% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
Average Return
-75.60%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -75.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SXTP Analyst Recommendation Trends
Rating
Jul 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
1
1
0
2
2
Buy
0
0
0
0
0
Hold
4
6
7
6
4
Sell
6
6
5
2
3
Strong Sell
0
0
0
0
0
total
11
13
12
10
9
Each month's total comprises the sum of three months' worth of ratings.
SXTP Financial Forecast
SXTP Stock Forecast FAQ
What is SXTP’s average 12-month price target, according to analysts?
Based on analyst ratings, 60 Degrees Pharmaceuticals, Inc.’s 12-month average price target is 4.40.
What is SXTP’s upside potential, based on the analysts’ average price target?
60 Degrees Pharmaceuticals, Inc. has 417.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SXTP a Buy, Sell or Hold?
60 Degrees Pharmaceuticals, Inc. has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is 60 Degrees Pharmaceuticals, Inc.’s price target?
The average price target for 60 Degrees Pharmaceuticals, Inc. is 4.40. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.00 ,the lowest forecast is $2.80. The average price target represents 417.65% Increase from the current price of $0.85.
The highest analyst price target is $6.00 ,the lowest forecast is $2.80. The average price target represents 417.65% Increase from the current price of $0.85.
What do analysts say about 60 Degrees Pharmaceuticals, Inc.?
60 Degrees Pharmaceuticals, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of SXTP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.